GEN News Highlights - News of the Week

Quick Links In the News Analysis & Insight GEN Article Webinars   Online Exclusives App Notes More at GEN Subscriber Tools   HIGHLIGHTS OF THE WEEK December 31, 2010 - January 6, 2011 View email in a browser           Forward to a colleague SPONSORED LINK Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc. FREE summary, plus donation to GAVI, or ACS Click Here! Receive FREE summary January 06, 2011, 10:03 AM EST Investigators Identify Prognostic Marker for Treating Hep C with Peg-Interferon and Ribavirin Team expects to launch a test based on the IP-10 marker this year. January 06, 2011, 09:40 AM EST Researchers Develop Simpler, Quicker Way of Producing AAV-Based Vectors for Gene Transfer Method is also capable of producing high yields of multiple AAV serotypes and efficient packaging. January 06, 2011, 10:06 AM EST CHO Genome Sequenced by BGI and GT Life Sciences Next step is data analysis and interpretation of genetic regulation in cell proliferation. January 06, 2011, 10:04 AM EST Genentech and Pfizer Join the Antibody-Drug Conjugate Bandwagon Genentech will tap Spirogen's technology and Pfizer will use Seattle Genetics'. January 06, 2011, 08:08 AM EST Symphogen Raises About $134M to Progress Clinical-Stage Antibodies Firm claims fundraising is largest ever in Europe by private biotech business. January 05, 2011, 09:57 AM EST Rituximab Biosimilar to Be Developed by Spectrum and Viropro Roche/Genentech's mAb therapeutic raked in $5.6 billion in 2009 sales, and patents start expiring in 2014. January 05, 2011, 09:09 AM EST Merck KGaA Buys Chinese Cell Culture Media Firm Beijing Skywing for About $18.8M It is hoped that the new client base in China will provide promising opportunities for Merck Millipore. January 05, 2011, 08:53 AM EST Beckman Coulter to Develop aNK Assay for Pivotal Trial of Transgene's NSCLC Drug French company projects that Phase IIb/III study with TG4010 will start later this year. January 04, 2011, 10:29 AM EST Genetic Link for Depression Furthered by Analysis of 54 Studies Results challenge an evaluation of 14 studies that contradicted the initial discovery of this association. January 04, 2011, 09:55 AM EST Pfizer Pays $14M to Expand RNA Partnership with Santaris Pharma Pfizer is adding 10 more targets, which could draw $600 million in milestones. January 03, 2011, 09:43 AM EST Sigma-Aldrich Takes Over Cerilliant to Pad Analytical Chemistry Portfolio Acquired firm has over 2,800 products related to reference standards and materials. You can view more news broken down into over 90 categories and updated daily. Analysis & Insight 2010 in Review: Biotechnology Highlights Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.     More A&Is Article from GEN's January 1 Issue Is Innovation Finally Beginning to Pay Off? The success rate in 2010 can be chalked up to the focus on cutting-edge technologies. Webinars Available on Demand: Original Broadcast Date - December 16, 2010 Simplifying Targeted Protein Quantification with Mass Spec: The SRM Atlas and Multiplexed MRM Protein Assays Sponsored by: Agilent Technologies In Case You Missed It: If you couldn't attend a previous webinar, be sure to check out our On-Demand Archives. Application Note Library Analysis of an O-linked Glycopeptide Using Multiple Stage Mass Spectrometry Reliability of Size Exclusion Chromatography Measurements on the ACQUITY UPLC H-Class Bio System Reproducible Dispensing of Live Cells with the Thermo Scientific Multidrop Combi Reagent Dispenser Improving Immunoassay Sensitivity Using IDBS ActivityBase to Enable Biofuel Discovery More App Notes Online Exclusives BLOGBIOTECH: Will FDA Bid Adieu to Auld Lang Syne and Open Up to New Drugs and Devices    More Blogs More at GEN GEN Subscriber Tools Subscription Center l Unsubscribe l Update Your Profile l About GEN IMPORTANT! Make sure you receive your chosen GEN e-Newsletters. Add update@genengnews.com to your Address Book or Safe Senders List. It's easy! Click HERE for instructions. Contact Us For: Advertising   Editorial   Business and Partnership Opportunities This email was sent by: Genetic Engineering & Biotechnology News 140 Huguenot St., New Rochelle, NY 10801, USA

CHO Genome Sequenced by BGI and GT Life Sciences

Quick Links In the News Analysis & Insight Webinars App Notes   Online Exclusives More at GEN Subscriber Tools   GEN NEWS HIGHLIGHTS Thursday, January 6, 2011 View email in a browser           Forward to a colleague SPONSORED LINK Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc. FREE summary, plus donation to GAVI, or ACS Click Here! Receive FREE summary CHO Genome Sequenced by BGI and GT Life Sciences Next step is data analysis and interpretation of genetic regulation in cell proliferation. Genentech and Pfizer Join the Antibody-Drug Conjugate Bandwagon Genentech will tap Spirogen's technology and Pfizer will use Seattle Genetics'. Symphogen Raises About $134M to Progress Clinical-Stage Antibodies Firm claims fundraising is largest ever in Europe by private biotech business. Investigators Identify Prognostic Marker for Treating Hep C with Peg-Interferon and Ribavirin Team expects to launch a test based on the IP-10 marker this year. Researchers Develop Simpler, Quicker Way of Producing AAV-Based Vectors for Gene Transfer Method is also capable of producing high yields of multiple AAV serotypes and efficient packaging. Cell Medica and Baylor's CAGT Ally to Commercialize EBV-CTL Cancer Therapy Partners will develop commercial GMP process and hope to start Phase II/III study in 2012. GSK Licenses Immutep's T-Cell Depleting Antibodies for Autoimmune Diseases Firm hopes selective depletion of activated T cells will lead to longer-lasting, safer therapy. Horizon and University of Washington Partner to Apply Gene Editing to IPSCs $400,000 project aims to generate new X-Man cell lines and bioproduction reagents. Receptos and Lilly Enter Agreement Focused on a GPCR Target Receptos' technology will be used to find small molecule modulators. Chiva Nabs Chinese Rights to Ligand's Hep B and HCC Candidates Use of Ligand's HepDirect tech for the development of new candidates against hep B, hep C, and HCC part of deal. You can view more news broken down into over 90 categories and updated daily. Analysis & Insight 2010 in Review: Biotechnology Highlights Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.     More A&Is Webinars Available on Demand: Original Broadcast Date - December 16, 2010 Simplifying Targeted Protein Quantification with Mass Spec: The SRM Atlas and Multiplexed MRM Protein Assays Sponsored by: Agilent Technologies In Case You Missed It: If you couldn't attend a previous webinar, be sure to check out our On-Demand Archives. Application Note Library Analysis of an O-linked Glycopeptide Using Multiple Stage Mass Spectrometry Reliability of Size Exclusion Chromatography Measurements on the ACQUITY UPLC H-Class Bio System Reproducible Dispensing of Live Cells with the Thermo Scientific Multidrop Combi Reagent Dispenser Improving Immunoassay Sensitivity Using IDBS ActivityBase to Enable Biofuel Discovery More App Notes Online Exclusives BLOGBIOTECH: Will FDA Bid Adieu to Auld Lang Syne and Open Up to New Drugs and Devices    More Blogs More at GEN GEN Subscriber Tools Subscription Center l Unsubscribe l Update Your Profile l About GEN IMPORTANT! Make sure you receive your chosen GEN e-Newsletters. Add update@genengnews.com to your Address Book or Safe Senders List. It's easy! Click HERE for instructions. Contact Us For: Advertising   Editorial   Business and Partnership Opportunities This email was sent by: Genetic Engineering & Biotechnology News 140 Huguenot St., New Rochelle, NY 10801, USA

Rituximab Biosimilar to Be Developed by Spectrum and Viropro

Quick Links In the News Analysis & Insight Webinars App Notes   Online Exclusives More at GEN Subscriber Tools   GEN NEWS HIGHLIGHTS Wednesday, January 5, 2011 View email in a browser           Forward to a colleague Rituximab Biosimilar to Be Developed by Spectrum and Viropro Roche/Genentech's mAb therapeutic raked in $5.6 billion in 2009 sales, and patents start expiring in 2014. Beckman Coulter to Develop aNK Assay for Pivotal Trial of Transgene's NSCLC Drug French company projects that Phase IIb/III study with TG4010 will start later this year. DBV Raises $25.5M in Series C for Clinical-Stage Food Allergy Desensitization Technology DBV's Viaskin platform is already undergoing human testing in patients with peanut and milk allergies. SPONSORED LINK Make your Biomanufacturing voice heard! Support effective industry growth & planning. 8th Annual Biomanufacturing study benchmarks critical global trends: Budget, new technologies, capacity, outsourcing hiring, downstream, disposables, expression systems, cost cutting, quality, more. BioPlan Associates, Inc. FREE summary, plus donation to GAVI, or ACS Click Here! Receive FREE summary Merck KGaA Buys Chinese Cell Culture Media Firm Beijing Skywing for About $18.8M It is hoped that the new client base in China will provide promising opportunities for Merck Millipore. Omeros Gains Rights to Antifibrinolytic Agents Candidates were licensed from The Regents of the University of California. Thomson Reuters and ChemAxon Couple Offerings to Search and Visualize Chemical Patents Users can now research Markush structures using ChemAxon's JChem software platform. Cephalon to Evaluate ImmunGene's mAb-Cytokine Fusion Technology for Six Cancer Targets ImmunGene claims this platform efficiently targets cancer cells and reduces cytokine toxicity. Lilly to Use ArGEN-X Technology for mAb R&D The Simple Antibody platform will be utilized, and Lilly will supply targets. Lonza to Leverage IDBS' Data Management and Execution Solution Bioprocess Execution System will allow storing of data in context and more efficient sharing between groups. AstraZeneca Turns to Kinaxo to Study PTMs Related to an Oncology Program Kinaxo's Cellular Target Profiling technology combines mass spec and software capabilities. Almirall and Forest Project Mid-2011 Aclidinium Filing as Third Phase III COPD Trial Triumphs Firms also anticipate starting Phase III combination-therapy studies during second half of 2011. You can view more news broken down into over 90 categories and updated daily. Analysis & Insight 2010 in Review: Biotechnology Highlights Gene patenting and ESCs were back in the headlines along with breakthroughs in sequencing, syn bio, and other fields.     More A&Is Webinars Available on Demand. Original Broadcast Date - December 16, 2010 Simplifying Targeted Protein Quantification with Mass Spec: The SRM Atlas and Multiplexed MRM Protein Assays Sponsored by: Agilent Technologies In Case You Missed It: If you couldn't attend a previous webinar, be sure to check out our On-Demand Archives. Application Note Library Stability Testing an Antibody Therapeutic in Different Formulations Using Dynamic Multi-Mode Spectroscopy (DMS) Turbidometric Growth Curve Measurements and Liquid Evaporation Studies with a Microplate Photometer Mapping Protein Stability Using Automated CD Outstanding Sensitivity for Confident Label-Free Interaction Analysis Analysis of an O-linked Glycopeptide Using Multiple Stage Mass Spectrometry More App Notes Online Exclusives BLOGBIOTECH: Will FDA Bid Adieu to Auld Lang Syne and Open Up to New Drugs and Devices    More Blogs More at GEN GEN Subscriber Tools Subscription Center l Unsubscribe l Update Your Profile l About GEN IMPORTANT! Make sure you receive your chosen GEN e-Newsletters. Add update@genengnews.com to your Address Book or Safe Senders List. It's easy! Click HERE for instructions. Contact Us For: Advertising   Editorial   Business and Partnership Opportunities This email was sent by: Genetic Engineering & Biotechnology News 140 Huguenot St., New Rochelle, NY 10801, USA

Scholarship World Wide

Basic Stipendien - What You Free College Geld wissen sollten
Artikel zur Verfügung gestellt von bioindo.blogspot.com

Einige Schüler und Eltern, die "Wissenschaft" sind andere als die verworrenen Hochschule: Studenten Darlehen, FAFSA, Nachhilfe, EFC, Stipendien, Arbeit zu studieren. Sie sind noch nicht in der Lage, mehr über das Prozess-Know-Stipendium, Tausende von Dollar sparen versuchen, die Kosten der Bildung zu decken.

Was ist das Stipendium?
Die Stipendien werden in verschiedenen Formen angeboten, aber sie sind in der Regel "geschenktes Geld" für das College. Anders als Darlehen, Stipendien wollen nicht den Stipendiengeber zahlen. Einige Stipendien werden an Studenten in Form von direkten Kontrolle vergeben, während andere Stipendien an der Heimatuniversität oder Fachhochschule geschrieben werden. Mehrere Arten von Anbietern Thema Stipendien: Vereine und Organisationen, Stiftungen, Unternehmen, Schulen, Universitäten, Regierungsbehörden und andere.

Wer kann Stipendien?
Dies ist ein verbreiteter Irrtum, dass Stipendien nur zu "korrigieren-A" Student. In der Tat, es gibt alle Arten von Stipendien für alle Studierenden, einschließlich derjenigen, die weniger als perfekte Zeugnisse sind. Einige Stipendien sind für Athleten, schrieb einige der Schüler in bestimmten Bereichen, und andere für Zivildiener. Einige Anbieter Stipendium möchte nur, um Studenten für das Leben in der Stadt oder des Landes Belohnung! Auch Studenten glauben irrtümlich, dass nur die obligatorischen Abiturienten College-Stipendien beantragen. Die Stipendien sind für Studenten verfügbar auf allen Ebenen im ersten Jahr Undergraduate-und Postgraduate Doktoranden. Es gibt auch Zuschüsse eine nicht-traditionelle Lerner, und umgekehrt.

So finden Sie Stipendien für Studenten?
Finden Stipendien kann ein langer Prozess, aber nicht, wenn die Studierenden die Forschungsförderung von zuverlässigen und präzisen Service im Internet, wie ScholarshipExperts.com. Die Schüler können auch beantragen, dass die örtliche Schule beratend Leitlinien oder kommen für nationale Preise. Die Schüler sollten an College finanzielle Hilfe Büro oder Universität sie teilnehmen möchten, wenn sie kommen für Stipendien von der Schule angeboten werden.

Wenn die Schüler sehen für Stipendien?
Jede Anwendung hat ihre eigenen Fristen. Es gibt Tausende von Stipendienprogrammen in den Frühling und Sommer Termine und mehr Zeit im Herbst und Winter. Der Schlüssel ist, nie aufhören Suche nach neuen Stipendium führt, auch in der anfänglichen ersten Jahr am College. Eine gute Faustregel ist es, auf der Suche nach Stipendien während der akademischen Laufbahn.